147 related articles for article (PubMed ID: 36708371)
1. Open-label phase II clinical trial of ketoconazole as CYP17 inhibitor in metastatic or advanced non-resectable granulosa cell ovarian tumors: the GREKO (GRanulosa Et KetOconazole) trial, GETHI 2011-03.
Garcia-Donas J; Hurtado A; Garrigos L; Santaballa A; Redondo A; Vidal L; Lainez N; Guerra E; Rodriguez V; Cueva J; Bover I; Palacio I; Rubio MJ; Prieto M; Lopez-Guerrero JA; Rodriguez-Moreno JF; Garcia-Casado Z; Garcia-Martinez E; Taus A; de Castro IP; Navarro P; Grande E;
Clin Transl Oncol; 2023 Jul; 25(7):2090-2098. PubMed ID: 36708371
[TBL] [Abstract][Full Text] [Related]
2. Mutational analysis (c.402C>G) of the FOXL2 gene and immunohistochemical expression of the FOXL2 protein in testicular adult type granulosa cell tumors and incompletely differentiated sex cord stromal tumors.
Hes O; Vaněček T; Petersson F; Grossmann P; Hora M; Perez Montiel DM; Steiner P; Dvořák M; Michal M
Appl Immunohistochem Mol Morphol; 2011 Jul; 19(4):347-51. PubMed ID: 21293260
[TBL] [Abstract][Full Text] [Related]
3. Cytochrome P17 inhibition with ketoconazole as treatment for advanced granulosa cell ovarian tumor.
Garcia-Donas J; Hurtado A; García-Casado Z; Albareda J; López-Guerrero JA; Alemany I; Grande E; Camara JC; Hernando S
J Clin Oncol; 2013 Apr; 31(10):e165-6. PubMed ID: 23358981
[No Abstract] [Full Text] [Related]
4. FOXL2 interacts with steroidogenic factor-1 (SF-1) and represses SF-1-induced CYP17 transcription in granulosa cells.
Park M; Shin E; Won M; Kim JH; Go H; Kim HL; Ko JJ; Lee K; Bae J
Mol Endocrinol; 2010 May; 24(5):1024-36. PubMed ID: 20207836
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of wild-type but not C134W mutant FOXL2 enhances GnRH-induced cell apoptosis by increasing GnRH receptor expression in human granulosa cell tumors.
Cheng JC; Klausen C; Leung PC
PLoS One; 2013; 8(1):e55099. PubMed ID: 23372819
[TBL] [Abstract][Full Text] [Related]
6. The specificity of the FOXL2 c.402C>G somatic mutation: a survey of solid tumors.
Schrader KA; Gorbatcheva B; Senz J; Heravi-Moussavi A; Melnyk N; Salamanca C; Maines-Bandiera S; Cooke SL; Leung P; Brenton JD; Gilks CB; Monahan J; Huntsman DG
PLoS One; 2009 Nov; 4(11):e7988. PubMed ID: 19956657
[TBL] [Abstract][Full Text] [Related]
7. The FOXL2 mutation (c.402C>G) in adult-type ovarian granulosa cell tumors of three Japanese patients: clinical report and review of the literature.
Takahashi A; Kimura F; Yamanaka A; Takebayashi A; Kita N; Takahashi K; Murakami T
Tohoku J Exp Med; 2013 Dec; 231(4):243-50. PubMed ID: 24257635
[TBL] [Abstract][Full Text] [Related]
8. Mutational analysis of FOXL2 p.C134W and expression of bone morphogenetic protein 2 in Japanese patients with granulosa cell tumor of ovary.
Oseto K; Suzumori N; Nishikawa R; Nishikawa H; Arakawa A; Ozaki Y; Asai H; Kawai M; Mizuno K; Takahashi S; Shirai T; Yamada-Namikawa C; Nakanishi M; Kajiyama H; Kikkawa F; Sugiura-Ogasawara M
J Obstet Gynaecol Res; 2014 May; 40(5):1197-204. PubMed ID: 24689977
[TBL] [Abstract][Full Text] [Related]
9. FOXL2 molecular testing in ovarian neoplasms: diagnostic approach and procedural guidelines.
Kommoss S; Anglesio MS; Mackenzie R; Yang W; Senz J; Ho J; Bell L; Lee S; Lorette J; Huntsman DG; Blake Gilks C
Mod Pathol; 2013 Jun; 26(6):860-7. PubMed ID: 23348906
[TBL] [Abstract][Full Text] [Related]
10. Differential apoptotic activities of wild-type FOXL2 and the adult-type granulosa cell tumor-associated mutant FOXL2 (C134W).
Kim JH; Yoon S; Park M; Park HO; Ko JJ; Lee K; Bae J
Oncogene; 2011 Apr; 30(14):1653-63. PubMed ID: 21119601
[TBL] [Abstract][Full Text] [Related]
11. Pathogenesis and treatment of adult-type granulosa cell tumor of the ovary.
Färkkilä A; Haltia UM; Tapper J; McConechy MK; Huntsman DG; Heikinheimo M
Ann Med; 2017 Aug; 49(5):435-447. PubMed ID: 28276867
[TBL] [Abstract][Full Text] [Related]
12. Ovarian cellular fibromas lack FOXL2 mutations: a useful diagnostic adjunct in the distinction from diffuse adult granulosa cell tumor.
McCluggage WG; Singh N; Kommoss S; Huntsman DG; Gilks CB
Am J Surg Pathol; 2013 Sep; 37(9):1450-5. PubMed ID: 23774170
[TBL] [Abstract][Full Text] [Related]
13. The role of FOXL2 in the pathogenesis of adult ovarian granulosa cell tumours.
Rosario R; Cohen PA; Shelling AN
Gynecol Oncol; 2014 May; 133(2):382-7. PubMed ID: 24342437
[TBL] [Abstract][Full Text] [Related]
14. Mutation of FOXL2 in granulosa-cell tumors of the ovary.
Shah SP; Köbel M; Senz J; Morin RD; Clarke BA; Wiegand KC; Leung G; Zayed A; Mehl E; Kalloger SE; Sun M; Giuliany R; Yorida E; Jones S; Varhol R; Swenerton KD; Miller D; Clement PB; Crane C; Madore J; Provencher D; Leung P; DeFazio A; Khattra J; Turashvili G; Zhao Y; Zeng T; Glover JN; Vanderhyden B; Zhao C; Parkinson CA; Jimenez-Linan M; Bowtell DD; Mes-Masson AM; Brenton JD; Aparicio SA; Boyd N; Hirst M; Gilks CB; Marra M; Huntsman DG
N Engl J Med; 2009 Jun; 360(26):2719-29. PubMed ID: 19516027
[TBL] [Abstract][Full Text] [Related]
15. A current perspective on the pathological assessment of FOXL2 in adult-type granulosa cell tumours of the ovary.
Kommoss S; Gilks CB; Penzel R; Herpel E; Mackenzie R; Huntsman D; Schirmacher P; Anglesio M; Schmidt D; Kommoss F
Histopathology; 2014 Feb; 64(3):380-8. PubMed ID: 24192202
[TBL] [Abstract][Full Text] [Related]
16. Impact of FOXL2 mutations on signaling in ovarian granulosa cell tumors.
Leung DTH; Fuller PJ; Chu S
Int J Biochem Cell Biol; 2016 Mar; 72():51-54. PubMed ID: 26791928
[TBL] [Abstract][Full Text] [Related]
17. Aromatase is a direct target of FOXL2: C134W in granulosa cell tumors via a single highly conserved binding site in the ovarian specific promoter.
Fleming NI; Knower KC; Lazarus KA; Fuller PJ; Simpson ER; Clyne CD
PLoS One; 2010 Dec; 5(12):e14389. PubMed ID: 21188138
[TBL] [Abstract][Full Text] [Related]
18. Functional exploration of the adult ovarian granulosa cell tumor-associated somatic FOXL2 mutation p.Cys134Trp (c.402C>G).
Benayoun BA; Caburet S; Dipietromaria A; Georges A; D'Haene B; Pandaranayaka PJ; L'Hôte D; Todeschini AL; Krishnaswamy S; Fellous M; De Baere E; Veitia RA
PLoS One; 2010 Jan; 5(1):e8789. PubMed ID: 20098707
[TBL] [Abstract][Full Text] [Related]
19. Prognostic significance of FOXL2 mutation and mRNA expression in adult and juvenile granulosa cell tumors of the ovary.
D'Angelo E; Mozos A; Nakayama D; Espinosa I; Catasus L; Muñoz J; Prat J
Mod Pathol; 2011 Oct; 24(10):1360-7. PubMed ID: 21623383
[TBL] [Abstract][Full Text] [Related]
20. Minireview: roles of the forkhead transcription factor FOXL2 in granulosa cell biology and pathology.
Pisarska MD; Barlow G; Kuo FT
Endocrinology; 2011 Apr; 152(4):1199-208. PubMed ID: 21248146
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
